Aequus Pharmaceuticals Inc
TSXV:AQS
Canada / Healthcare / Pharmaceuticals
Exchange Data
Hide this widget
Price
0.0050 CAD
Day change
0 (0.00%)
52-week range
0.0050 - 0.040
21:01 - Closed
Summary of Aequus Pharmaceuticals Inc
Hide this widget
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on commercializing value-added products in specialty therapeutic areas in Can...
Next Earnings
1 May 2025
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
-0.01 (-50.00%)
Data Explorer
Hide this widget
Search metric that you want to observe. Create your own widget, customise and rearrange metrics
| Metric Name | Value | Trend |
|---|---|---|
| Dividend Yield | 0.0% | |
| P/E Ratio | -0.2x | |
| Revenue | 413.165 K | |
| Net Income to Company | - |
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| AQS | Peers | Sector | |
|---|---|---|---|
Market Cap | 663.172 K | 12.459 M | 88.372 M |
Price % of 52 Week High | Premium | 40.7% | 60.4% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | Premium | -3.7% | -0.7% |
1 Year Price Total Return | -66.7% | -43.0% | -12.3% |
Beta (5 Year) | -0.35 | 0.70 | 0.64 |
In the News
Hide this widget
No data available
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for Aequus Pharmaceuticals is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Financial Models for Aequus Pharmaceuticals Inc
Model Gallery
Hide this widget
| DuPont ROE AnalysisView Updated 6 days ago |
| 10Y Historical FinancialsView Updated 6 days ago |
| 5Y Historical FinancialsView Updated 6 days ago |
| P/E MultiplesView Updated 12 hours ago |
| Price / Book MultiplesView Updated 12 hours ago |
| Price / Sales MultiplesView Updated 12 hours ago |
| EV / Revenue MultiplesView Updated 12 hours ago |
| 10Y DCF EBITDA ExitView Updated 12 hours ago |
| 10Y DCF Revenue ExitView Updated 12 hours ago |
| 10Y DCF Growth ExitView Updated 12 hours ago |
| 5Y DCF EBITDA ExitView Updated 12 hours ago |
| 5Y DCF Revenue ExitView Updated 12 hours ago |
| 5Y DCF Growth ExitView Updated 12 hours ago |
| Earnings Power ValueView Updated 12 hours ago |
| EV / EBIT MultiplesView Updated 12 hours ago |
| EV / EBITDA MultiplesView Updated 12 hours ago |
| CAPM WACC ModelView Updated 19 hours ago |
Historical Financials
Full Financials
Hide this widget
| (CAD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Sept-24 | Sept-23 | Sept-24 |
| Income Statement | |||||
| Revenue | 1.38 | 0.25 | 0.41 | 0.01 | 0.15 |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | (2.58) | (2.81) | (2.48) | (0.77) | (0.55) |
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 2.78 | 5.06 | 6.54 | 4.09 | 6.54 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | (1.95) | (2.29) | (2.48) | (0.65) | (0.35) |
Analyst Notes
April 21, 2025
Hide this widget